21/04/2014 03:08:29 Free Membership Login

Myriad Genetics News (NASDAQ:MYGN)

DateTimeSource
Headline
04/11/20149:00AMZACKSGilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
Gilead Sciences Inc. (GILD) saw a big move last session, as the company’s shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GILD, as the stock is now down almost 18% in the past one-month... More...>>
04/07/20144:30PMGLOBEMyriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)
SALT LAKE CITY, April 7, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has submitted the first module of a premarket approval (PMA) application to the Food and Drug Administration (FDA) for the use of BRACAnalysis® testing as a companion diagnostic with olaparib. Olaparib is... More...>>
04/03/20148:00AMPRNUSMarket Signal - Stocks Hitting New High -- Research on Myriad Genetics, Linear Technology, TE Connectivity, and Dover
Market Signal - Stocks Hitting New High -- Research on Myriad Genetics, Linear Technology, TE Connectivity, and Dover Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON, April 3, 2014 LONDON, April 3, 2014 /PRNewswire/ -- The trading session on Wednesday, April 02, 2014 ended... More...>>
03/25/20147:05AMGLOBEMyriad to Present Seven Clinical Studies at the Annual Clinical Genetics Meeting
SALT LAKE CITY, March 25, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that results from seven clinical studies will be presented at the upcoming American College of Medical Genetics (ACMG) annual meeting, which will be held Mar. 25-Mar.29, 2013 in Nashville, Tennessee. "We believe clinical... More...>>
03/24/20147:05AMGLOBEMyriad Announces HRD Companion Diagnostic Collaboration With Tesaro
SALT LAKE CITY, March 24, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that Tesaro, Inc. will use Myriad's novel HRD (homologous recombination deficiency) test to identify tumor types that may respond to its investigational poly-ADP ribose polymerase (PARP) inhibitor, niraparib, currently... More...>>
03/20/20144:00PMGLOBEInstitut Pasteur and Myriad RBM Publish Initial Results From Landmark Study of Immune Response
PARIS and SALT LAKE CITY, March 20, 2014 (GLOBE NEWSWIRE) -- Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced they have published an initial data analysis from the landmark Milieu Interieur Project in the journal Immunity, which provided new insights into the healthy... More...>>
03/20/20147:05AMGLOBESGO Updates Hereditary Cancer Recommendations
SALT LAKE CITY, March 20, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today noted that the Society of Gynecologic Oncology (SGO) has issued new clinical practice statements surrounding hereditary cancer testing for patients with ovarian and endometrial cancer. The statements are consistent with the recently... More...>>
03/12/20148:00AMPRNUSDividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes o...
Dividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes on H&R Block, Ulta Beauty, Myriad, QIAGEN, and Nutrisystem Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, March 12, 2014 NEW YORK, March 12... More...>>
03/04/20147:05AMGLOBENCCN Updates Guidelines for Hereditary Colon Cancer Testing
SALT LAKE CITY, March 4, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today is pleased to note that the National Comprehensive Cancer Network (NCCN) has revised its medical guidelines to expand Lynch syndrome screening. Lynch syndrome is the most common cause of hereditary colon cancer in adults. Myriad... More...>>
03/03/20147:00AMGLOBEMyriad Publishes Clinical Utility Study for Prolaris(R)
SALT LAKE CITY, March 3, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it has published data from the PROCEDE 500 study in the journal Current Medical Research and Opinion, demonstrating that 65 percent of physicians changed their original treatment plans for men with prostate cancer... More...>>
02/19/20142:50PMZACKSMyriad Genetics Unveils Prolaris Data - Analyst Blog
Shares of Myriad Genetics Inc. (MYGN) surged 11.4% at yesterday’s market close following the company’s recent release of positive data on its Prolaris test – a 46-gene molecular diagnostic test – in the Journal of Urology. The Prolaris test correctly predicted those prostrate cancer patients who... More...>>
02/18/20147:05AMGLOBEMyriad Genetics Publishes Prolaris(R) Data in the Journal of Urology
SALT LAKE CITY, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced it has published data in the Journal of Urology demonstrating that its Prolaris test accurately predicted, based on biopsy specimens, which men would develop biochemical recurrence (BCR) or metastatic disease following... More...>>
02/07/20147:00AMGLOBEBRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit
HOUSTON and SALT LAKE CITY, Feb. 7, 2014 (GLOBE NEWSWIRE) -- Gene by Gene, Ltd. and Myriad Genetics, Inc., the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, Inc., and the Trustees of the University of Pennsylvania (the "Patent Owners") have reached an agreement... More...>>
02/05/20144:47PMDJNMARKET SNAPSHOT: U.S. Stocks Fall; Data Stoke Fears Of Slowdown
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks ended Wednesday's choppy session lower as investors were unable to shrug off worries over the economy. A weaker-than-expected ADP jobs report and the ISM report on the services side of the economy compounded fears that the U.S. recovery is still vulnerable... More...>>
02/05/20142:11PMDJNMARKET SNAPSHOT: U.S. Stocks Eye Rebound; Dow Reverses Losses
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rebounded from their session lows, with the Dow Jones Industrial Average breaking into positive territory, as investors digested the ISM services-sector survey and private-sector jobs report from ADP. After recent selling on Wall Street the main indexes... More...>>
02/05/201411:42AMDJNMARKET SNAPSHOT: U.S. Stocks Fall To Session Lows After ISM, ADP
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks moved sharply lower on Wednesday, briefly erasing the previous day's modest gains, after a report on the services sector failed to repair sentiment bruised by a weak ADP jobs report. As volatility has been rising steadily, some analysts say the main... More...>>
02/05/201410:53AMDJNMARKET SNAPSHOT: U.S. Stocks Fall To Session Lows After ISM, ADP
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks moved sharply lower on Wednesday, briefly erasing the previous day's modest gains, after a report on the services sector failed to repair sentiment bruised after a weak ADP jobs report. Investors will also pay attention to two Fed officials speaking... More...>>
02/05/201410:13AMDJNMARKET SNAPSHOT: U.S. Stocks Open Lower On Weak ADP Report
By Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks opened lower on Wednesday, unable to follow through on the previous day's modest gains, after a weaker-than-expected ADP jobs report. More economic signals will come later in the Institute for Supply Management's non-manufacturing survey. Investors will... More...>>
02/05/20149:38AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Wednesday's session are Aramark Holdings Corp. (ARMK), C.H. Robinson Worldwide Inc. (CHRW) and Merck & Co. (MRK). 3M Co. (MMM) unveiled a new $12 billion share-buyback program, continuing the industrial-products maker's practice of using cash flow to fund... More...>>
02/05/20149:37AMDJNMARKET SNAPSHOT: U.S. Stock Futures Turn Up Before Market Open
By Barbara Kollmeyer and Anora Mahmudova, MarketWatch NEW YORK (MarketWatch) -- U.S. stock futures turned up Wednesday, shrugging off the weaker-than-expected ADP employment report. More economic signals will come later in the Institute for Supply Management's nonmanufacturing survey. Futures for the Dow Jones Industrial... More...>>


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq mygn140421 03:08